HomeNewsBusinessMoneycontrol ResearchRain Industries: Operational carbon business getting back to track

Rain Industries: Operational carbon business getting back to track

March 02, 2020 / 17:23 IST
Story continues below Advertisement

Highlights: - Decline in realisations of carbon and advanced materials
Steady operating performance, unlike peers, is noteworthy
Higher allocation of green petcoke and traction in key projects are positive
Other than end-market challenges, supply chain impact due to coronavirus needs a close watch
-------------------------------------------------

Rain Industries’ (CMP: Rs 103/share; market capitalisation: Rs 3,475 crore) quarterly result was weighted down by weak realisations for carbon and advance material products, majorly reflecting the sharp decline in the prices of oil derivatives. Sequentially, volumes sold was relatively better for carbon products, which is noticeable given the weak end-markets. Operating performance was much ahead of peers – Himadri Chemicals (coal tar pitch) and Goa Carbon (calcined petroleum coke).

Q4 CY19 financials Source: Company

Q4 product sales volume trend Source: Company

Key highlights Carbon products (67 percent of Q4 CY19 sales) revenue declined 21 percent year-on-year on account of steep decrease in realisations.

Sequentially, lower realisations were particularly visible for CPC (calcined petroleum coke), but this was more than offset by better volumes. The average blended realisation for carbon products decreased by about 8 percent due to weaker end-market of aluminium. In spite of this, profitability per tonne for carbon products has been stable. In the preceding quarter, the company was able to get rid of its high-cost inventory, which has helped segmental margins to normalise to near historical levels.

Story continues below Advertisement

In case of advance materials segment (24 percent of sales), sales volumes were affected by lower demand for products in steel, graphite and North America construction industries. The weak performance was also attributed to sluggish demand for resins by adhesive players and European automakers. Average blended realisation in this segment decreased by about 7 percent due to a decline in prices across the crude oil value chain.

Key observations:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show

Status on petcoke import restrictions Sequential improvement in CPC volumes sold point towards a normalisation in production volume throughput, which have been affected by import restrictions for CPC import, and import quotas for GPC (green petcoke). Note that the company’s earlier business model required it to import CPC from its US plant, blend and re-export it. But due to the import ban, the company was not able to pursue this blending process, which aids margins as well.